NCT05952687 2024-03-27Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid TumorsSt. Jude Children's Research HospitalPhase 1 Withdrawn